SCHEMBL5376629

SCHEMBL5376629

COC(=O)c1cc(S(=O)(=O)Nc2ccc(SCc3ccc(C)c(C)c3)cc2)ccc1C

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 1/20 0.52
POLB P06746 3/20 0.51
PABPC1 P11940 1/20 0.50
HTT P42858 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.47
GFER P55789 1/20 0.47
ALDH1A1 P00352 4/20 0.46
MAPT P10636 4/20 0.46
TSHR P16473 3/20 0.46
GAA P10253 1/20 0.46
ALOX15 P16050 1/20 0.46
LMNA P02545 3/20 0.43
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PKM P14618 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5380795 0.90 POLB (0.47) CASP6POLBPABPC1HTTNPSR1
SCHEMBL5373887 0.90 POLB (0.49) CASP6POLBPABPC1HTTNPSR1
SCHEMBL5382317 0.90 POLB (0.51) CASP6POLBPABPC1HTTNPSR1
SCHEMBL5375209 0.89 POLB (0.58) CASP6POLBPABPC1HTTNPSR1
SCHEMBL5368231 0.89 PLAU (0.53) CASP6POLBPABPC1HTTNPSR1
SCHEMBL5378678 0.88 POLB (0.50) CASP6POLBPABPC1HTTNPSR1
SCHEMBL5376596 0.88 POLB (0.49) CASP6POLBPABPC1HTTNPSR1
SCHEMBL5368417 0.87 ALOX15 (0.48) CASP6POLBPABPC1HTTNPSR1
SCHEMBL5382518 0.87 POLB (0.47) CASP6POLBPABPC1HTTNPSR1
SCHEMBL5377045 0.86 SMN1; SMN2 (0.54) CASP6POLBPABPC1HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD CASP6 3606/4885POLB 1807/4885PABPC1 3612/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD CASP6 3811/4885POLB 2006/4885PABPC1 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.